Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 18336966)


The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys.

Teigler JE, Phogat S, Franchini G, Hirsch VM, Michael NL, Barouch DH.

J Virol. 2014 Feb;88(3):1809-14. doi: 10.1128/JVI.02386-13. Epub 2013 Nov 20.


L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.

Pacchioni SM, Bissa M, Zanotto C, Morghen Cde G, Illiano E, Radaelli A.

J Transl Med. 2013 Apr 11;11:95. doi: 10.1186/1479-5876-11-95.


Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.

Zhao Y, Tahiliani V, Salek-Ardakani S, Croft M.

Front Immunol. 2012 Nov 8;3:332. doi: 10.3389/fimmu.2012.00332. eCollection 2012.


Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.

Dimier J, Ferrier-Rembert A, Pradeau-Aubreton K, Hebben M, Spehner D, Favier AL, Gratier D, Garin D, Crance JM, Drillien R.

J Virol. 2011 May;85(10):5016-26. doi: 10.1128/JVI.02359-10. Epub 2011 Mar 2.


Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.

Rehm KE, Roper RL.

Vaccine. 2011 Apr 12;29(17):3276-83. doi: 10.1016/j.vaccine.2011.02.023. Epub 2011 Feb 23.


Smallpox vaccines: targets of protective immunity.

Moss B.

Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x. Review.


Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.

Green S, Ennis FA, Mathew A.

Vaccine. 2011 Feb 11;29(8):1666-76. doi: 10.1016/j.vaccine.2010.12.036. Epub 2010 Dec 31.


The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.

Salek-Ardakani S, Flynn R, Arens R, Yagita H, Smith GL, Borst J, Schoenberger SP, Croft M.

J Clin Invest. 2011 Jan;121(1):296-307. doi: 10.1172/JCI42056. Epub 2010 Dec 22.


The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Kennedy RB, Poland GA.

Virology. 2010 Dec 20;408(2):232-40. doi: 10.1016/j.virol.2010.09.013. Epub 2010 Oct 18.


Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Ramasamy S, Liu CQ, Tran H, Gubala A, Gauci P, McAllister J, Vo T.

Br J Pharmacol. 2010 Oct;161(4):721-48. doi: 10.1111/j.1476-5381.2010.00939.x. Review.


Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.

Meisinger-Henschel C, Späth M, Lukassen S, Wolferstätter M, Kachelriess H, Baur K, Dirmeier U, Wagner M, Chaplin P, Suter M, Hausmann J.

J Virol. 2010 Oct;84(19):9907-19. doi: 10.1128/JVI.00756-10. Epub 2010 Jul 28.


Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.

Nájera JL, Gómez CE, García-Arriaza J, Sorzano CO, Esteban M.

PLoS One. 2010 Jun 30;5(6):e11406. doi: 10.1371/journal.pone.0011406.


Smallpox vaccines for biodefense.

Kennedy RB, Ovsyannikova I, Poland GA.

Vaccine. 2009 Nov 5;27 Suppl 4:D73-9. doi: 10.1016/j.vaccine.2009.07.103. Review.


Vaccinia virus vaccines: past, present and future.

Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR.

Antiviral Res. 2009 Oct;84(1):1-13. doi: 10.1016/j.antiviral.2009.06.006. Epub 2009 Jun 26. Review.


Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Midgley CM, Putz MM, Weber JN, Smith GL.

J Gen Virol. 2008 Dec;89(Pt 12):2992-7. doi: 10.1099/vir.0.2008/004440-0.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk